NEW YORK (GenomeWeb News) - Caliper Life Sciences said today that it has received a contract from the National Institutes of Environmental Health Services valued at up to $7 million to develop customized transgenic and knockout mouse models though its Xenogen Biosciences business.
The company said the contract will begin immediately and could run up to 10 years “at the option of NIEHS.” The contract was awarded to Caliper through a competitive bid process.
Caliper said the NIEHS will use the genetically modified mouse models as part of its research to identify and possibly prevent hazardous conditions and exposure in humans.
Caliper said it has made over 9,000 unique mouse and rat models, some of which have already been supplied to the NIEHS through a previous multi-year agreement.
Xenogen is the in vivo pharmaceutical drug-discovery branch of Caliper Discovery Alliances & Services.